Grifols SA (GRFS)
Grifols Market Cap : 5.605B for April 30, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 2.010M |
| Cellectis SA | 394.32M |
| Trinity Biotech Plc | 11.52M |
| Akari Therapeutics Plc | 6.238M |
| NuCana Plc | 8.740M |
Market Cap Related Metrics
| PE Ratio | 12.22 |
| PS Ratio | 0.6582 |
| PEG Ratio | 0.0718 |
| Price to Book Value | 2.386 |
| Price to Free Cash Flow | 7.922 |
| Price | 8.235 |
| Earnings Yield | 8.18% |
| PEGY Ratio | 0.0709 |
| Operating PE Ratio | 3.957 |
| Normalized PE Ratio | 12.80 |